FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

10 results

fingolimod
(FINGOLIMOD)
Aurobindo Pharma Limited
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
fingolimod
(Fingolimod)
Camber Pharmaceuticals, Inc.
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 years and older.
fingolimod
(Fingolimod)
Dr. Reddy's Laboratories Inc
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
fingolimod
(FINGOLIMOD)
Biocon Pharma Inc.
Usage: Fingolimod capsules are indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 years and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
fingolimod
(FINGOLIMOD)
Quallent Pharmaceuticals Health LLC
Usage: Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients aged 10 and older.
mayzent
(siponimod)
Novartis Pharmaceuticals Corporation
Usage: MAYZENT is indicated for treating relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
ponvory
(Ponesimod)
Janssen Pharmaceuticals, Inc.
Usage: PONVORY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
ponvory
(Ponesimod)
Vanda Pharmaceuticals Inc.
Usage: PONVORY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
tascenso odt
(Fingolimod Lauryl Sulfate)
Cycle Pharmaceuticals Ltd
Usage: TASCENSO ODT is indicated for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 and older, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
zeposia
(ozanimod hydrochloride)
Celgene Corporation
Usage: ZEPOSIA is indicated for the treatment of relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease) and moderately to severely active ulcerative colitis in adults.

Sphingosine 1-phosphate Receptor Modulator class drugs

fingolimod

fingolimod

fingolimod

fingolimod

fingolimod

mayzent

ponvory

ponvory

tascenso odt

zeposia